blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1591108

EP1591108 - Solution formulations of sirolimus and its analogs for CAD treatment [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.01.2017
Database last updated on 24.04.2024
Most recent event   Tooltip13.07.2018Lapse of the patent in a contracting state
New state(s): LU, TR		published on 15.08.2018  [2018/33]
Applicant(s)For all designated states
Cordis Corporation
14201 N.W. 60th Avenue
Miami Lakes
Florida 33014 / US
[2016/11]
Former [2005/44]For all designated states
Cordis Corporation
14201 N.W. 60th Avenue Miami Lakes
Florida 33014 / US
Inventor(s)01 / Falotico, Robert
40 Black Horse Run
Belle Mead, NJ 08502 / US
02 / Zhao, Jonathon Z.
12 Briar Hill Court
Belle Mead, NJ 08502 / US
 [2005/44]
Representative(s)Kirsch, Susan Edith, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2014/12]
Former [2009/51]Mercer, Christopher Paul, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA / GB
Former [2005/44]Mercer, Christopher Paul, et al
Carpmaels & Ransford, 43-45 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date05252016.031.03.2005
[2005/44]
Priority number, dateUS2004081396531.03.2004         Original published format: US 813965
[2005/44]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1591108
Date:02.11.2005
Language:EN
[2005/44]
Type: A3 Search report 
No.:EP1591108
Date:29.08.2007
[2007/35]
Type: B1 Patent specification 
No.:EP1591108
Date:16.03.2016
Language:EN
[2016/11]
Search report(s)(Supplementary) European search report - dispatched on:EP01.08.2007
ClassificationIPC:A61K9/08, A61K47/10, A61K31/436, A61K47/22, A61L31/16
[2015/04]
CPC:
A61L31/16 (EP,US); A61K31/436 (EP,US); A61K31/4745 (EP,US);
A61K47/10 (EP,US); A61K47/22 (EP,US); A61K9/0019 (EP,US);
A61P9/00 (EP); A61P9/10 (EP); A61P9/12 (EP);
A61P9/14 (EP); A61L2300/416 (EP,US) (-)
Former IPC [2005/44]A61K9/22, A61K47/10, A61K31/436
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/11]
Former [2005/44]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Formulierungen von Sirolimus und seine Analoge in Lösungsform zur Behandlung von koronaren Herzkrankheit[2005/44]
English:Solution formulations of sirolimus and its analogs for CAD treatment[2005/44]
French:Formulations en solution de sirolimus et ses analogues pour le traitement de la coronaropathie[2005/44]
Examination procedure07.02.2008Examination requested  [2008/12]
09.06.2008Despatch of a communication from the examining division (Time limit: M06)
19.12.2008Reply to a communication from the examining division
18.07.2011Despatch of a communication from the examining division (Time limit: M04)
27.09.2011Reply to a communication from the examining division
16.06.2014Despatch of a communication from the examining division (Time limit: M04)
17.10.2014Reply to a communication from the examining division
28.01.2015Communication of intention to grant the patent
21.05.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
11.09.2015Communication of intention to grant the patent
14.01.2016Fee for grant paid
14.01.2016Fee for publishing/printing paid
14.01.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.06.2008
Opposition(s)19.12.2016No opposition filed within time limit [2017/08]
Fees paidRenewal fee
14.03.2007Renewal fee patent year 03
14.03.2008Renewal fee patent year 04
13.03.2009Renewal fee patent year 05
15.03.2010Renewal fee patent year 06
15.03.2011Renewal fee patent year 07
14.03.2012Renewal fee patent year 08
11.03.2013Renewal fee patent year 09
12.03.2014Renewal fee patent year 10
10.03.2015Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.03.2005
AT16.03.2016
CY16.03.2016
CZ16.03.2016
DK16.03.2016
EE16.03.2016
ES16.03.2016
FI16.03.2016
LT16.03.2016
MC16.03.2016
PL16.03.2016
RO16.03.2016
SE16.03.2016
SI16.03.2016
SK16.03.2016
TR16.03.2016
LU31.03.2016
BG16.06.2016
GR17.06.2016
IS16.07.2016
PT18.07.2016
[2018/32]
Former [2018/28]HU31.03.2005
AT16.03.2016
CY16.03.2016
CZ16.03.2016
DK16.03.2016
EE16.03.2016
ES16.03.2016
FI16.03.2016
LT16.03.2016
MC16.03.2016
PL16.03.2016
RO16.03.2016
SE16.03.2016
SI16.03.2016
SK16.03.2016
BG16.06.2016
GR17.06.2016
IS16.07.2016
PT18.07.2016
Former [2017/37]AT16.03.2016
CZ16.03.2016
DK16.03.2016
EE16.03.2016
ES16.03.2016
FI16.03.2016
LT16.03.2016
PL16.03.2016
RO16.03.2016
SE16.03.2016
SI16.03.2016
SK16.03.2016
BG16.06.2016
GR17.06.2016
IS16.07.2016
PT18.07.2016
Former [2017/19]AT16.03.2016
CZ16.03.2016
DK16.03.2016
EE16.03.2016
ES16.03.2016
FI16.03.2016
LT16.03.2016
PL16.03.2016
RO16.03.2016
SE16.03.2016
SK16.03.2016
BG16.06.2016
GR17.06.2016
IS16.07.2016
PT18.07.2016
Former [2017/07]AT16.03.2016
CZ16.03.2016
DK16.03.2016
EE16.03.2016
ES16.03.2016
FI16.03.2016
LT16.03.2016
PL16.03.2016
RO16.03.2016
SE16.03.2016
SK16.03.2016
GR17.06.2016
IS16.07.2016
PT18.07.2016
Former [2016/51]AT16.03.2016
CZ16.03.2016
EE16.03.2016
ES16.03.2016
FI16.03.2016
LT16.03.2016
PL16.03.2016
RO16.03.2016
SE16.03.2016
SK16.03.2016
GR17.06.2016
IS16.07.2016
PT18.07.2016
Former [2016/50]AT16.03.2016
CZ16.03.2016
EE16.03.2016
ES16.03.2016
FI16.03.2016
LT16.03.2016
PL16.03.2016
RO16.03.2016
SE16.03.2016
SK16.03.2016
GR17.06.2016
IS16.07.2016
Former [2016/49]EE16.03.2016
FI16.03.2016
LT16.03.2016
PL16.03.2016
SE16.03.2016
GR17.06.2016
IS16.07.2016
Former [2016/48]FI16.03.2016
LT16.03.2016
SE16.03.2016
GR17.06.2016
IS16.07.2016
Former [2016/39]FI16.03.2016
LT16.03.2016
SE16.03.2016
GR17.06.2016
Former [2016/36]FI16.03.2016
LT16.03.2016
GR17.06.2016
Former [2016/35]FI16.03.2016
GR17.06.2016
Documents cited:Search[X]WO9319763  (AMERICAN HOME PROD [US]) [X] 1-4,6,8-10 * example - *;
 [A]EP0950386  (CORDIS CORP [US]) [A] 1-10 * page 5 - page 6 ** claim - *;
 [X]US2003170287  (PRESCOTT MARGARET FORNEY [US]) [X] 1-3,6,8-10 * example 3 * * paragraph [0067]; claim - *;
 [X]WO2004011000  (WYETH CORP [US], et al) [X] 1-3,5-10 * example - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.